Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Your email has been successfully registered.
If everything goes well, the drug would be ready to be commercialized in two years.
Mexico’s National Network of State Science and Technology Councils and Organizations (Rednacecyt) reported that Switzerland’s Paul Scherrer Institute will support Mexican researchers who are looking for a drug against COVID-19.
The Pachuca Polytechnic University project is conceptualized in two stages. The first, to investigate how a nanoparticle would interact with the compounds that are projected to be used in the medicine. And the second stage is knowing how it would act with the virus.
Huerta explained that, if everything goes well, the concept will be validated next year and, perhaps, it would be ready to be commercialized in two years.
"If we look at it over the two-year horizon, it's a very short time regarding how drug development occurs, and the time is reduced because the experience is being used for other viruses," Huerta said.